# A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis

> **NCT07102888** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Plaque Psoriasis in Children
- Plaque Psoriasis in Adolescents

## Interventions

- **DRUG:** RSS0393 Ointment

## Key facts

- **NCT ID:** NCT07102888
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07102888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07102888, "A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07102888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*